基本信息:
- 专利标题: ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS
- 申请号:PCT/US2018/066366 申请日:2018-12-19
- 公开(公告)号:WO2019126253A8 公开(公告)日:2019-06-27
- 发明人: DYCKMAN, Alaric J. , MUSSARI, Christopher P. , HAQUE, Tasir Shamsul , WHITELEY, Brian K. , POSY, Shoshana L. , KUMAR, Sreekantha Ratna , PASUNOORI, Laxman , HEGDE, Subramanya , RAMACHANDRA REDDY, Anupama Kandhi , ANUMULA, Rushith Kumar
- 申请人: BRISTOL-MYERS SQUIBB COMPANY
- 申请人地址: Route 206 and Province Line Road Princeton, New Jersey 08543 US
- 专利权人: BRISTOL-MYERS SQUIBB COMPANY
- 当前专利权人: BRISTOL-MYERS SQUIBB COMPANY
- 当前专利权人地址: Route 206 and Province Line Road Princeton, New Jersey 08543 US
- 代理机构: GREENBLATT, Gary D. et al.
- 优先权: US62/607,998 20171220
- 主分类号: C07D209/12
- IPC分类号: C07D209/12 ; C07D401/04 ; C07D401/10 ; C07D401/12 ; C07D401/14 ; C07D403/14 ; C07D413/14 ; C07D417/14 ; C07D451/02 ; C07D453/02 ; C07D471/04 ; C07D487/04 ; C07D513/04 ; A61P37/00 ; A61K31/4353
摘要:
Disclosed are compounds of Formula (I) or salts thereof, wherein A, G, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
公开/授权文献:
- WO2019126253A1 ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS 公开/授权日:2019-06-27
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D209/00 | 杂环化合物,含五元环、与其他环稠合、带1个氮原子作为惟一的杂环原子 |
--------C07D209/02 | .与一个碳环稠合 |
----------C07D209/04 | ..吲哚;氢化吲哚 |
------------C07D209/10 | ...有被杂原子取代的烃基,直接连在杂环的碳原子上 |
--------------C07D209/12 | ....被氧原子取代的基 |